Skip to content

Study · Animal study (in vivo) · rat · 2000

7 results

[The effect of semax and mexidol on the course of acute pancreatitis in rats].

Ivanov IuV, Iasnetsov VV

Eksperimental'naia i klinicheskaia farmakologiia1 Jan 2000Cited by 2 (Europe PMC)

PMID10763109 (opens in a new tab)PepBankPUB-10763109

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study7

7 results from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Efficacy outcome

    In rats with acute pancreatitis, a single administration of semax (or mexidol) markedly reduced the loss of animals, to 10-13%.

    In plain wordsIn rats with pancreatitis, one dose of semax (or mexidol) markedly lowered animal deaths, to 10-13%.

    Peptide
    Semax
    Outcome
    DecreaseLoss of animals in acute pancreatitis
    Study

    ratsn: not reported in source

    Acute pancreatitis
    Outcome group
    Mortality · Gastrointestinal
    Studied dose
    Dose not stated · intraductal or intraperitoneal · single administrationAs given in this study (rats).

    Measurements

    Animal loss
    10 to 13%
    semax or mexidol

    Source sentences

    Summary
    a single intraductal or intraperitoneal administration of semax or mexidol markedly reduces the loss of experimental animals (to 10-13%)
    1 context sentence
    Summary · context
    The effect of semax and mexidol on the course of acute pancreatitis in rats was studied in comparison with the action of contrical, fluorouracil, and dibunol.
  2. 02AnimalAnimal study (in vivo)Efficacy outcome

    In rats with acute pancreatitis, semax (or mexidol) decreased hyperfermentemia.

    In plain wordsIn rats with pancreatitis, semax (or mexidol) lowered the raised enzyme levels in blood.

    Peptide
    Semax
    Outcome
    DecreaseHyperfermentemia
    Study

    ratsn: not reported in source

    Acute pancreatitis
    Outcome group
    Inflammation markers · Gastrointestinal
    Studied dose
    Dose not stated · intraductal or intraperitoneal · single administrationAs given in this study (rats).

    Source sentences

    Summary
    a single intraductal or intraperitoneal administration of semax or mexidol markedly reduces the loss of experimental animals (to 10-13%), decreases hyperfermentemia
    1 context sentence
    Summary · context
    The effect of semax and mexidol on the course of acute pancreatitis in rats was studied in comparison with the action of contrical, fluorouracil, and dibunol.
  3. 03AnimalAnimal study (in vivo)Efficacy outcome

    In rats with acute pancreatitis, semax (or mexidol) decreased activation of lipid peroxidation.

    In plain wordsIn rats with pancreatitis, semax (or mexidol) lowered fat-damage activity (lipid peroxidation).

    Peptide
    Semax
    Outcome
    DecreaseLipid peroxidation activation
    Study

    ratsn: not reported in source

    Acute pancreatitis
    Outcome group
    Inflammation markers · Gastrointestinal
    Studied dose
    Dose not stated · intraductal or intraperitoneal · single administrationAs given in this study (rats).

    Source sentences

    Summary
    a single intraductal or intraperitoneal administration of semax or mexidol markedly reduces the loss of experimental animals (to 10-13%), decreases hyperfermentemia, lipid peroxidation activation
    1 context sentence
    Summary · context
    The effect of semax and mexidol on the course of acute pancreatitis in rats was studied in comparison with the action of contrical, fluorouracil, and dibunol.
  4. 04AnimalAnimal study (in vivo)Efficacy outcome

    In rats with acute pancreatitis, semax (or mexidol) decreased vascular permeability.

    In plain wordsIn rats with pancreatitis, semax (or mexidol) lowered leakiness of blood vessels.

    Peptide
    Semax
    Outcome
    DecreaseVascular permeability
    Study

    ratsn: not reported in source

    Acute pancreatitis
    Outcome group
    Inflammation markers · Gastrointestinal
    Studied dose
    Dose not stated · intraductal or intraperitoneal · single administrationAs given in this study (rats).

    Source sentences

    Summary
    a single intraductal or intraperitoneal administration of semax or mexidol markedly reduces the loss of experimental animals (to 10-13%), decreases hyperfermentemia, lipid peroxidation activation, and vascular permeability
    1 context sentence
    Summary · context
    The effect of semax and mexidol on the course of acute pancreatitis in rats was studied in comparison with the action of contrical, fluorouracil, and dibunol.
  5. 05AnimalAnimal study (in vivo)Efficacy outcome

    In rats with acute pancreatitis, semax (or mexidol) improved microcirculation.

    In plain wordsIn rats with pancreatitis, semax (or mexidol) improved small blood vessel flow.

    Peptide
    Semax
    Outcome
    IncreaseMicrocirculation
    Study

    ratsn: not reported in source

    Acute pancreatitis
    Outcome group
    Vascular function · Gastrointestinal
    Studied dose
    Dose not stated · intraductal or intraperitoneal · single administrationAs given in this study (rats).

    Source sentences

    Summary
    a single intraductal or intraperitoneal administration of semax or mexidol markedly reduces the loss of experimental animals (to 10-13%), decreases hyperfermentemia, lipid peroxidation activation, and vascular permeability, improves microcirculation
    1 context sentence
    Summary · context
    The effect of semax and mexidol on the course of acute pancreatitis in rats was studied in comparison with the action of contrical, fluorouracil, and dibunol.
  6. 06AnimalAnimal study (in vivo)Efficacy outcome

    In rats with acute pancreatitis, semax (or mexidol) accelerated healing of damaged pancreatic zones by substitutional repair of pancreatic acini without coarse fibrous changes.

    In plain wordsIn rats with pancreatitis, semax (or mexidol) sped up healing of damaged pancreas areas without heavy scarring.

    Peptide
    Semax
    Outcome
    IncreaseHealing of damaged pancreatic zones
    Study

    ratsn: not reported in source

    Acute pancreatitis
    Outcome group
    Wound healing · Gastrointestinal
    Studied dose
    Dose not stated · intraductal or intraperitoneal · single administrationAs given in this study (rats).

    Source sentences

    Summary
    accelerates healing of the damaged pancreatic zones by substitutional repair of pancreatic acini not accompanied by coarse fibrous changes in the parenchyma
    1 context sentence
    Summary · context
    The effect of semax and mexidol on the course of acute pancreatitis in rats was studied in comparison with the action of contrical, fluorouracil, and dibunol.
  7. 07AnimalAnimal study (in vivo)Efficacy outcome

    In rats with acute pancreatitis, intraductal semax and mexidol were more effective than contrical, fluorouracil and dibunol.

    In plain wordsIn rats with pancreatitis, semax and mexidol given into the pancreatic duct worked better than three comparison drugs.

    Peptide
    Semax
    Outcome
    IncreaseEfficacy versus contrical, fluorouracil and dibunol (intraductal)
    Study

    ratsn: not reported in source

    Acute pancreatitis
    Comparator
    Contrical, fluorouracil and dibunol
    Outcome group
    Gastrointestinal protection · Gastrointestinal
    Studied dose
    Dose not stated · intraductal · single administrationAs given in this study (rats).

    Source sentences

    Summary
    Upon the intraductal administration, semax and mexidol were more effective than contrical, fluorouracil, and dibunol.
    1 context sentence
    Summary · context
    The effect of semax and mexidol on the course of acute pancreatitis in rats was studied in comparison with the action of contrical, fluorouracil, and dibunol.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    12 Oct 2026, 17:28 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:04 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.